The store will not work correctly when cookies are disabled.
5-Furan-2-yl-7,8,9,10-tetrahydro-6H-12-thia-2,4,11-triaza-cyclohepta[b]fluoren-1-ylamine
ID: ALA1089956
PubChem CID: 46884408
Max Phase: Preclinical
Molecular Formula: C18H16N4OS
Molecular Weight: 336.42
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Nc1ncnc2c1sc1nc3c(c(-c4ccco4)c12)CCCCC3
Standard InChI: InChI=1S/C18H16N4OS/c19-17-16-15(20-9-21-17)14-13(12-7-4-8-23-12)10-5-2-1-3-6-11(10)22-18(14)24-16/h4,7-9H,1-3,5-6H2,(H2,19,20,21)
Standard InChI Key: JVRQFNMKPQDNAA-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 28 0 0 0 0 0 0 0 0999 V2000
3.5766 -4.3492 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.5788 -2.6981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2924 -3.1084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2898 -3.9402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0800 -4.1997 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
3.5731 -1.8731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2399 -1.3876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9842 -0.6033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1593 -0.6042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9053 -1.3889 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.0842 -2.8540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5672 -3.5292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3915 -3.4476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7337 -2.6915 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2456 -2.0161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4230 -2.1011 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.8722 -4.1179 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.2087 -2.5844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3760 -2.7965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0517 -3.5427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8675 -3.1036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8606 -3.9338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1787 -4.4683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4031 -4.2822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6 7 2 0
14 15 1 0
3 2 2 0
15 16 2 0
16 11 1 0
2 21 1 0
13 17 1 0
3 4 1 0
22 1 1 0
1 4 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 6 1 0
2 6 1 0
4 5 1 0
11 12 2 0
5 12 1 0
12 13 1 0
11 3 1 0
13 14 2 0
18 19 1 0
19 20 1 0
18 21 1 0
22 23 1 0
23 24 1 0
24 20 1 0
21 22 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 336.42 | Molecular Weight (Monoisotopic): 336.1045 | AlogP: 4.35 | #Rotatable Bonds: 1 |
Polar Surface Area: 77.83 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 2.64 | CX LogP: 3.80 | CX LogD: 3.80 |
Aromatic Rings: 4 | Heavy Atoms: 24 | QED Weighted: 0.52 | Np Likeness Score: -1.46 |
References
1. Lockman JW, Reeder MD, Suzuki K, Ostanin K, Hoff R, Bhoite L, Austin H, Baichwal V, Adam Willardsen J.. (2010) Inhibition of eEF2-K by thieno[2,3-b]pyridine analogues., 20 (7): [PMID:20189382] [10.1016/j.bmcl.2010.02.005] |